Severe Psoriatic Disease in the Setting of Hypocalcemia

Citation data:

CONFERENCE: Research Appreciation Day

Publication Year:
2017
Usage 11
Abstract Views 11
Repository URL:
https://digitalcommons.hsc.unt.edu/rad/RAD17/Other/32
Author(s):
Ashleigh Workman; Workman, Ashleigh, OMS-III; Reagin, Heather, D.O.; Weis, Stephen, D.O.
Tags:
UNT Health
poster description
Purpose: To present a patient suffering from severe psoriatic disease in the setting of hypocalcemia and determine the best treatment.Methods: N/AResults: The patient’s psoriatic plaques cleared three months after presentation when she had achieved normocalcemia with 0.75 mcg calcitriol.Conclusions: Psoriasis is a chronic, inflammatory, systemic disease that affects approximately three percent of the US adult population. While its exact cause is uncertain, it is thought to be an autoimmune disorder. There have been very rare cases of psoriasis developing in patients with hypocalcemia. Treatment of such patients is directed at restoring the calcium to the normal range, not immunosuppressive medications.